Skip to content

PHARMACIE DAVOINE: what changed

BE 0444.488.642NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€46,694
2024 · €95,876-€142,571
Equity
€144,505
2024 · €191,200-€46,694
Cash
€26,051
2024 · €76,144-€50,093
Balance sheet total
€2.0m
2024 · €1.6m+€329,386

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€355,492

    up €355,492 (+68.5%), from €519,160 to €874,651

    of which Land and buildings: +€356,338

  • Receivables within one year +€57,724

    up €57,724 (+7.9%), from €728,181 to €785,905

    of which Trade receivables: +€55,837

  • Cash -€50,093

    down €50,093 (-65.8%), from €76,144 to €26,051

    mainly Investment in fixed assets (net) (-€428,239) and Receivables within one year (-€57,724)

  • Stocks and contracts -€31,315

    down €31,315 (-10.4%), from €302,279 to €270,964

Equity and liabilities
  • Debts after one year +€276,793

    up €276,793 (+101%), from €273,953 to €550,746

  • Trade debts +€68,478

    up €68,478 (+21.2%), from €322,962 to €391,440

  • Profit (loss) carried forward -€46,694

    down €46,694, from €0 to -€46,694

Income statement
  • Gross operating margin -€89,401

    down €89,401 (-19.9%), from €449,339 to €359,938

  • Other operating charges +€39,943

    up €39,943 (+134%), from €29,804 to €69,747

  • Depreciation +€25,647

    up €25,647 (+54.5%), from €47,100 to €72,747

  • Financial charges +€16,612

    up €16,612 (+51.1%), from €32,502 to €49,114

  • Taxes -€9,399

    down €9,399 (-83.6%), from €11,240 to €1,841

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €95,876
Gross operating margin -€89,401
Staff costs -€672
Depreciation -€25,647
Other operating charges -€39,943
Other operating items +€19,389
Financial income +€916
Financial charges -€16,612
Taxes +€9,399
Result 2025 -€46,694
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€93,491
Investment -€428,239
Financing +€284,655
Cash 2024 €76,144
Net result for the year -€46,694
Depreciation +€72,747
Stocks and contracts +€31,315
Receivables within one year -€57,724
Deferred charges and accrued income +€2,422
Trade debts +€68,478
Tax, wage and social debts +€14,130
Other debts +€9,838
Accrued charges and deferred income -€1,019
Investment in fixed assets (net) -€428,239
Debts after one year +€276,793
Current portion of long-term debt +€7,862
Cash 2025 €26,051
brings cash intakes cash out
Every line side by side 54 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,647,424 €1,976,811 +€329,386 +20.0%
Fixed assets 21/28 €526,053 €881,544 +€355,492 +67.6%
Tangible fixed assets 22/27 €519,160 €874,651 +€355,492 +68.5%
Land and buildings 22 €406,687 €763,025 +€356,338 +87.6%
Plant, machinery and equipment 23 €27,275 €40,607 +€13,332 +48.9%
Furniture and vehicles 24 €85,197 €71,019 -€14,178 -16.6%
Financial fixed assets 28 €6,893 €6,893 = 0.0%
Current assets 29/58 €1,121,372 €1,095,266 -€26,106 -2.3%
Stocks and contracts in progress 3 €302,279 €270,964 -€31,315 -10.4%
Stocks 30/36 €302,279 €270,964 -€31,315 -10.4%
Amounts receivable within one year 40/41 €728,181 €785,905 +€57,724 +7.9%
Trade receivables 40 €179,503 €235,340 +€55,837 +31.1%
Other amounts receivable 41 €548,678 €550,565 +€1,887 +0.3%
Cash at bank and in hand 54/58 €76,144 €26,051 -€50,093 -65.8%
Deferred charges and accrued income 490/1 €14,768 €12,347 -€2,422 -16.4%
Total equity and liabilities 10/49 €1,647,424 €1,976,811 +€329,386 +20.0%
Equity 10/15 €191,200 €144,505 -€46,694 -24.4%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €129,200 €129,200 = 0.0%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €123,000 €123,000 = 0.0%
Profit (loss) carried forward 14 €0 -€46,694 -€46,694
Amounts payable 17/49 €1,456,225 €1,832,306 +€376,081 +25.8%
Amounts payable after more than one year 17 €273,953 €550,746 +€276,793 +101%
Financial debts 170/4 €273,953 €550,746 +€276,793 +101%
Amounts payable within one year 42/48 €1,181,253 €1,281,560 +€100,307 +8.5%
Current portion of amounts payable after more than one year 42 €94,226 €102,089 +€7,862 +8.3%
Financial debts 43 €250,000 €250,000 = 0.0%
Credit institutions 430/8 €250,000 €250,000 = 0.0%
Trade debts 44 €322,962 €391,440 +€68,478 +21.2%
Suppliers 440/4 €322,962 €391,440 +€68,478 +21.2%
Taxes, remuneration and social security 45 €24,863 €38,993 +€14,130 +56.8%
Taxes 450/3 €14,361 €13,073 -€1,288 -9.0%
Remuneration and social security 454/9 €10,502 €25,920 +€15,417 +147%
Other amounts payable 47/48 €489,201 €499,039 +€9,838 +2.0%
Accrued charges and deferred income 492/3 €1,019 €0 -€1,019 -100%
Non-recurring operating income 76A €37,716 €0 -€37,716 -100%
Remuneration, social security and pensions 62 €212,240 €212,912 +€672 +0.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €47,100 €72,747 +€25,647 +54.5%
Other operating charges 640/8 €29,804 €69,747 +€39,943 +134%
Non-recurring operating charges 66A €20,630 €1,241 -€19,389 -94.0%
Gross operating margin 9900 €449,339 €359,938 -€89,401 -19.9%
Operating profit (loss) 9901 €139,565 €3,291 -€136,274 -97.6%
Financial income 75/76B €54 €970 +€916 +1,699%
Recurring financial income 75 €54 €970 +€916 +1,699%
Financial charges 65/66B €32,502 €49,114 +€16,612 +51.1%
Recurring financial charges 65 €32,502 €49,114 +€16,612 +51.1%
Profit (loss) for the period before taxes 9903 €107,117 -€44,853 -€151,970
Income taxes 67/77 €11,240 €1,841 -€9,399 -83.6%
Profit (loss) for the period 9904 €95,876 -€46,694 -€142,571
Profit (loss) for the period to be appropriated 9905 €95,876 -€46,694 -€142,571

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€730,396 to €993,653

Midpoint €840,086 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €144,505
Capitalised earnings €1.3m to €1.8m
Indication €730,396 to €993,653

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€144,505
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€144,505

Capitalised earnings

net result for the year (9904)
2025
-€46,694
excluding non-recurring income and charges
-€45,454
2024
€95,876
excluding non-recurring income and charges
€78,790
2023
€524,030
excluding non-recurring income and charges
€519,506
2022
€537,637
2021
€480,655
Average result, excluding non-recurring income and charges
€184,280
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.3m / €1.5m / €1.8m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.